Swiftwater, PANCT06968975Now EnrollingIRB Ready

Polyneuropathy, Inflammatory Demyelinating, Chronic Clinical Trial in Swiftwater, PA

Access cutting-edge polyneuropathy, inflammatory demyelinating, chronic treatment through this clinical trial at a research site in Swiftwater. Study-provided care at no cost to qualified participants.

Sponsored by Sanofi

Quick Self-Assessment

See if you qualify for this Swiftwater location

Preparing your pre-screening questions…

Expert Care in Swiftwater

Access polyneuropathy, inflammatory demyelinating, chronic specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related polyneuropathy, inflammatory demyelinating, chronic treatment provided free

Apply for This Swiftwater Location

Check if you qualify for this polyneuropathy, inflammatory demyelinating, chronic clinical trial in Swiftwater, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Swiftwater

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Swiftwater site if eligible
  4. 4Begin participation

About This Polyneuropathy, Inflammatory Demyelinating, Chronic Study in Swiftwater

This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three months of treatment with standard of care therapy. The study is expected to last two years. Enrollment is expected to continue for one year. Depending on when the participant is enrolled, a participant can be followed for between one and two years, through the end of study, approximately two years after the study starts.

Sponsor: Sanofi

Who Can Participate

Inclusion Criteria

Participants are eligible to be included in the study only if all of the following criteria apply:
Neurologist-confirmed diagnosis of CIDP found in the medical record, with the last neurologist visit prior to enrollment containing no information that suggests this diagnosis was reversed
Active use of at least one of the following CIDP treatments for three months or longer, with no evidence of discontinuation of this therapy as of the last neurologist visit prior to enrollment
immunoglobulin
corticosteroids, with the exception of prednisone (or equivalent) monotherapy at 10mg or less per day
plasma exchange
efgartigimod alfa
azathioprine
mycophenolate mofetil
cyclosporine
methotrexate
Signed informed consent
Residual impairment, disability, or neurological deficits at enrollment, as defined by a raw I-RODS score of 44 or below

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:
Evidence of participation in any interventional clinical trial with an investigational drug at the time of enrollment
Hyperreflexia (increased reflexes) recorded in the medical record during a neurological exam the year before enrollment and after CIDP diagnosis
Aged under 18 at the time of enrollment The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Swiftwater?

Yes, this clinical trial (NCT06968975) has an active research site in Swiftwater, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Polyneuropathy, Inflammatory Demyelinating, Chronic Treatment Options in Swiftwater, PA

If you're searching for polyneuropathy, inflammatory demyelinating, chronic treatment options in Swiftwater, PA, this clinical trial (NCT06968975) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Swiftwater research site is actively enrolling participants for this clinical trial. You'll receive care from experienced polyneuropathy, inflammatory demyelinating, chronic specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all polyneuropathy, inflammatory demyelinating, chronic clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Swiftwater, PA

See all multiple myeloma clinical trials recruiting in Swiftwater — not just this study.

Browse Multiple Myeloma Trials in Swiftwater

Ready to Join in Swiftwater?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Swiftwater, PA